Modified FLOT Beats FOLFOX for Advanced Gastric Cancer

(MedPage Today) -- A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the first-line treatment of advanced HER2-negative gastric cancer, a phase III trial showed.
In the more...